alanylglutamine has been researched along with Sepsis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Han, S; Li, Y; Su, X; Zhang, Y | 1 |
| Apostolou, K; Briassouli, E; Briassoulis, G; Daikos, G; Goukos, D; Nanas, S; Routsi, C | 1 |
| Gatt, M; MacFie, J | 1 |
| Guimarães, SB; Sena, JI; Vasconcelos, PR | 1 |
| Biolo, G; Ciocchi, B; Guarnieri, G; Gullo, A; Iscra, F; Situlin, R; Toigo, G | 1 |
| Bergmann, M; Függer, R; Gornikiewicz, A; Manhart, N; Oehler, R; Roth, E; Sautner, T; Spittler, A | 1 |
1 review(s) available for alanylglutamine and Sepsis
| Article | Year |
|---|---|
Metabolic response to injury and sepsis: changes in protein metabolism.
Topics: Carnitine; Dipeptides; Humans; Nutritional Support; Proteins; Sepsis; Wounds and Injuries | 1997 |
2 trial(s) available for alanylglutamine and Sepsis
| Article | Year |
|---|---|
Randomized clinical trial of gut-specific nutrients in critically ill surgical patients.
Topics: Acute-Phase Reaction; Aged; Aged, 80 and over; Critical Illness; Dietary Supplements; Dipeptides; Female; Gastrointestinal Tract; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Recovery of Function; Sepsis; Treatment Outcome; Vitamins | 2010 |
Postoperative glycyl-glutamine infusion reduces immunosuppression: partial prevention of the surgery induced decrease in HLA-DR expression on monocytes.
Topics: Abdomen; Adult; Aged; Amino Acids; Dipeptides; Electrolytes; Female; Flow Cytometry; Glucose; HLA-DR Antigens; Humans; Immunosuppression Therapy; Infusions, Parenteral; Leukocyte Count; Lipopolysaccharides; Male; Middle Aged; Monocytes; Parenteral Nutrition Solutions; Postoperative Complications; Sepsis; Solutions; Time Factors; Tumor Necrosis Factor-alpha | 2001 |
3 other study(ies) available for alanylglutamine and Sepsis
| Article | Year |
|---|---|
Efficacy of alanyl glutamine in nutritional support therapy for patients with sepsis: A protocol for systematic review and meta-analysis.
Topics: APACHE; C-Reactive Protein; Critical Care Outcomes; Critical Illness; Dipeptides; Hemoglobins; Humans; Immunoglobulins; Meta-Analysis as Topic; Nutritional Support; Prealbumin; Randomized Controlled Trials as Topic; Research Design; Sepsis; Serum Albumin; Systematic Reviews as Topic; Treatment Outcome | 2021 |
Glutamine suppresses Hsp72 not Hsp90α and is not inducing Th1, Th2, or Th17 cytokine responses in human septic PBMCs.
Topics: Cytokines; Dipeptides; Glutamine; Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Sepsis; Th1 Cells; Th17 Cells; Th2 Cells | 2014 |
Metabolic changes induced by pre-administration of L-alanyl-glutamine and omega-3 in Wistar rats subjected to sepsis.
Topics: Animals; Anti-Inflammatory Agents; Dipeptides; Disease Models, Animal; Fatty Acids, Omega-3; Gluconeogenesis; Glycolysis; Immunologic Factors; Liver; Male; Muscle, Striated; Random Allocation; Rats; Rats, Wistar; Sepsis | 2010 |